Clinical trials aim to develop knowledge in a specific field. Trials help us understand and validate the effectiveness of new treatments.
Trials are regarded as the most responsible way of developing new medical interventions from research to public use. During trials, patients receive medical interventions (i.e. devices or drugs) and are observed by experts to monitor reactions.
Example: Lead by a Principal Investigator and an expert research team, 326 patients used Lenire for 12-weeks during TENT-A1 (Lenire Tinnitus Clinical Trial 1). 1
Peer Reviewed & Real World Research
Publication of clinical studies validates research and allows healthcare professionals to trust scientific research in pursuit of adopting new medical practices.
During peer review, independent experts evaluate and validate methodologies and claims to determine if the research is worthy of publication in scientific journals.
Lenire Tinnitus Clinical Trial Summaries
Learn more about how adding Lenire to your tinnitus treatment options. Visit the Lenire for Healthcare Professionals page. Get in touch to learn more about tinnitus clinic trials.
1. TENT-A1 Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020) 2. TENT-A2: Conlon et al., Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial, Sci Rep. 3. TENT-A3: Clinical trial data in preparation for independent publication: clinicaltrials.gov/ct2/show/NCT05227365. 4. Aggregate: TENT-A1, TENT-A2, TENT-A3 aggregate clinical trial results.
Note 1: All statistics based on compliant patients. Patient compliance criteria is detailed in Lenire’s clinical trial design. Note 2: TENT-A1/TENT-A2 were not considered by the United States of America FDA as part of Lenire’s FDA Grant and, as such, applies solely to outside the US.